Navigation Links
ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
Date:8/28/2008

tee of Roche Diabetes Care. From 1996 to 2003, he was President and CEO of Disetronic Medical Systems Inc., Minneapolis, USA, a medical device company which he developed into one of the fastest growing MedTech companies in the USA. When the company was sold to Roche in 2003, Disetronic Inc. had grown into a company of more than 200 people with sales of $50 million.

Dr. De Haes has also held senior positions in the pharmaceutical industry with Sandoz Pharma (now part of Novartis), where he led the development and commercialisation of the company's first biotech product. Dr. De Haes is a Medical Doctor, University of Leuven, Belgium, and holds a corporate MBA, University of St Thomas, Minneapolis, USA.

Professor Collen founded ThromboGenics as a spin-out of the University of Leuven and has led the Company since its inception. He has been pivotal in the Company's success, which was originally financed from the royalties of tPA, a product for the treatment of heart attacks, which was commercialised by the leading US biotech company Genentech. In the last several years, he has made a major contribution to the building of ThromboGenics' exciting development pipeline, as well as leading the Company through its successful IPO on Euronext Brussels in June 2006.

Dr. Patrik De Haes, commenting on his appointment said, "I am very pleased to have been appointed as the CEO of ThromboGenics at a very exciting time for the Company. Our recent licensing deal with Roche for TB-403, has allowed us to focus and invest in the clinical development of microplasmin, a product which we believe could be a major advance in the treatment of a number of important eye diseases. I look forward to continue working with Desire and the rest of the senior management team, to ensure we deliver significant shareholder value from our most attractive pipeline."

Professor Desire Collen, ThromboGenics' Chairman said, "I am glad that Patrik has agreed to become ThromboGenics' new
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
2. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
3. ThromboGenics N.V. - Business Update
4. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
5. ThromboGenics Announces 2007 Full Year Results
6. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
7. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
8. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
9. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
10. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
11. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 SoundConnect , an ... is proud to announce the strategic additions of ... their Boston, Charleston and Atlanta offices. SoundConnect’s ... demand for hosted solutions, collaboration and mobility that ... cost. , SoundConnect was founded in 2004, with ...
(Date:7/29/2014)... NASA technologists have hurdled a number of significant ... already revolutionary observing technology originally created for the ... by Principal Investigator Harvey Moseley, a scientist at ... has demonstrated that electrostatically actuated microshutter arrays ... voltage are as functional as the current ...
(Date:7/29/2014)... 2014   Sequenom, Inc. (NASDAQ: ... genetic analysis solutions, and Mayo Medical Laboratories (MML), ... the United States , have announced ... applications. "We have great appreciation for Mayo ... we welcome the opportunity to partner with the organization,s ...
(Date:7/29/2014)... Quantum Cheshire Cat: Can a particle be separated from ... Nature Communications , published the results of the first ... field, conducted by Chapman University in Orange, CA, and ... seen a cat without a grin," thought Alice in ... most curious thing I ever saw in my life!" ...
Breaking Biology Technology:SoundConnect Organization and Culture is Evolving 2Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4
... SEATTLE, May 14 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 2009 ... AM in Room 311 of Building A, Level 3. , ... BIO International Convention, ... 10:40 AM Eastern/4:40 PM Central European/7:40 AM Pacific, ...
... child,s gender with less ethically charged method at Reproductive ... RAMON, Calif., May 13 In response to growing ... of their next child, the Reproductive Science Center of ... it now is offering an alternative gender-selection technique with ...
... Dendreon Corporation (Nasdaq: DNDN ) announced today the ... shares of its common stock, which shares were offered for ... May 8, 2009, Deutsche Bank Securities Inc., acting as sole ... to purchase an additional 1,279,166 shares of common stock at ...
Cached Biology Technology:Gender-Selection Technique Embraced for Hopeful Parents 2Dendreon Announces Closing of Common Stock Offering 2Dendreon Announces Closing of Common Stock Offering 3
(Date:7/30/2014)... potential effects of climate change on the world,s ... wrong factors, according to a new paper by ... University of Queensland, and other organizations. The authors ... missing the point when it comes to climate ... change scientists focus on the "direct" threats of ...
(Date:7/30/2014)... Life Sciences Institute (SALSI), a joint venture between The ... University of Texas Health Science Center at San Antonio, ... Program. The winners, Emily Boice from UTSA and Lei ... for their project titled, "Novel engineered ferritins for tracking ... Boice and Huang,s research is focused on finding a ...
(Date:7/30/2014)... biologists, led by Clemson University associate professor Andrew S. ... will pave the way for novel anti-fouling paint for ... and industrial applications. , The team,s findings, published in ... larval stage of barnacles that attaches to a wide ... material that acts as an underwater heavy-duty adhesive. , ...
Breaking Biology News(10 mins):Conservation scientists asking wrong questions on climate change impacts on wildlife 2Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2
... San Diego State University researchers will lead a study ... The Guizhou snub-nosed monkey, often called the golden monkey. ... the National Science Foundation, student researchers from SDSU,s departments ... month to the Fanjingshan National Nature Reserve, home to ...
... efficient cars, buildings and domestic appliances to address climate change ... Research at the University of East Anglia. A report ... as much effort is being spent on developing energy supply technologies ... improving the efficiency with which energy is used. The ...
... Oct. 25, 2012 /PRNewswire-iReach/ -- New research shows that ... Maine have demonstrated improvements in health behaviors that persisted ... and rising health care costs continue to challenge employers, ... to reduce health risks and improve health behaviors. ...
Cached Biology News:SDSU researchers to study China's national treasure 2Efforts to mitigate climate change must target energy efficiency 2Efforts to mitigate climate change must target energy efficiency 3New Study Shows That Improvements in Employee Health Behaviors Persist Over Two Years 2
... Zero Blunt TOPO PCR ... fastest and easiest method ... or equal to95%) cloning ... amplified with proofreading thermostable ...
Quartz-Halogen, 100 W, High Intensity...
... The Baculovirus Expression System with ... recombinant pFastBac™ plasmids containing the polyhedrin ... to the baculovirus genome (bacmid DNA) ... E. coli cells. The recombinant bacmid ...
...
Biology Products: